The duality of sleeping sickness: Focusing on sleep

Sleep Medicine Reviews

Volumn 5, Issue 2, 2001, Pages 139-153

  Buguet, A ^a,b,c,d,e   Bourdon, L ^a,b,c,d,e   Bouteille, B ^a,b,c,d,e   Cespuglio, R ^a,b,c,d,e   Vincendeau, P ^a,b,c,d,e   Radomski, M W ^a,b,c,d,e   Dumas, M ^a,b,c,d,e  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b CENTRE DE RECHERCHES   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Circadian; Duality; Rhythms; Sleep; Sleeping sickness; Trypanosomiasis; Ultradian

Indexed keywords

AFRICAN TRYPANOSOMIASIS; ANTIBODY PRODUCTION; BLOOD BRAIN BARRIER; CELL MEDIATED CYTOTOXICITY; CIRCADIAN RHYTHM; COMPLEMENT ACTIVATION; ENDOCRINE SYSTEM; HOST PARASITE INTERACTION; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTIC INFILTRATION; NEUROLOGIC DISEASE; OPSONIZATION; PARASITE TRANSMISSION; PATHOGENESIS; PHAGOCYTOSIS; REVIEW; SLEEP WAKING CYCLE; TRYPANOSOMA BRUCEI; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; TSETSE FLY; ULTRADIAN RHYTHM;

EID: 0034916390     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1053/smrv.2000.0130     Document Type: Review

References (70)

1. The molecular evolution of trypanosomes
2. Identification of trypanosomes: From morphology to molecular biology
3. Trypanosoma brucei brucei and high-density lipoproteins: Old and new thoughts on the identity and mechanism of the trypanocidal factor in human serum
4. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high-density lipoprotein
5. Human African trypanosomiasis: Sleeping sickness
6. History of sleeping sickness in East Africa
7. Developments in the differentiation of Trypanosoma brucei
8. Antigenic variation in African trypanosomes
9. Human "healthy carriers" of Trypanosoma (brucei type) discovered by immunofluorescence test in the République démocratique du Congo
10. "Trypanosomiasis exists when it is searched for . . ."
11. Etat sanitaire et dépopulation au Congo
12. Prophylactic strategies in human African trypanosomiasis
13. Biological diagnosis of human African trypanosomiasis
14. A cardagglutination test with stained trypanosomes (CATT) for the serological diagnosis of T b gambiense trypanosomiasis
15. Lésions histologiques des centres nerveux dans la trypanosomiase humaine
16. Pathology of human African trypanosomiasis with reference to experimental African trypanosomiasis and infections of the central nervous system
17. Contribution à l'etude de la neurologie et neuropathologie de la trypanosomiase humaine
18. Human African trypanosomiasis (T b gambiense): A study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy
19. Cytokines in the pathogenesis of human African trypanosomiasis: Antagonistic roles of TNF-α and IL-10
20. Immunology of African trypanosomiasis
21. Induction of interferon-γ, transforming growth factor-β, and interleukin-4 in mouse strains with different susceptibilities to Trypanosoma brucei brucei
22. Surface receptors and transporters of Trypanosoma brucei
23. Plasma nitrate and interferon-gamma in Trypanosoma brucei rhodesiense infections: Evidence that nitric oxide production is induced during both early blood-stage and late meningoencephalitic-stage infections
24. Voltammetric detection of nitric oxide (NO) in the rat brain: Its variations throughout the sleep-wake cycle
25. Dualité d'action du monoxyde d'azote dans la trypanosomose africaine expérimentale
26. Monoxyde d'azote et maladie du sommeil
27. Effect of melarsoprol treatment on circulating IL-10 and TNF-α levels in human African trypanosomiasis
28. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis
29. Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes
30. Innate resistance to Trypanosoma congolense infections: Differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57B1/6 mice
31. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and protaglandins
32. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice
33. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections
34. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal
35. Circulating antibodies directed against tryptophan-like epitopes in sera of patients with human African trypanosomiasis
36. Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines
37. Hormones in human African trypanosomiasis
38. Trypanosoma brucei brucei: A long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders
39. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice
40. Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected by Trypanosoma brucei brucei
41. Chronic over-expression of proinflammatory cytokines and histopathology of the brains of rats infected with Trypanosoma brucei
42. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei
43. Un nouveau piège pour la capture des glossines (Glossina: Diptera, Muscidae): Description et essais sur le terrain
44. Practical application of measures for the control of tsetse-borne trypanosomiases of livestock
45. Present strategies in the treatment of human African trypanosomiasis
46. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: A randomised trial
47. Clinical aspects of human African trypanosomiasis
48. La maladie du sommeil en Afrique
49. 24-Hour polysomnographic evaluation in a patient with sleeping sickness
50. Sleep-wake cycle in human African trypanosomiasis
51. Reversal of the sleep-wake cycle disorder of sleeping sickness after trypanosomicide treatment
52. Sleep is changed by blood sampling through an indwelling venous catheter
53. Is sleeping sickness a circadian disorder? The serotonergic hypothesis
54. Disruption of endocrine rhythms in sleeping sickness with preserved relationship between hormonal pulsatility and the REM-NREM sleep cycles
55. Plasma melatonin rhythm is maintained in human African trypanosomiasis
56. Relationship of plasma growth hormone to slowwave sleep in African sleeping sickness
57. Nitric oxide in murine malaria: Divergent roles in blood and brain suggested by voltammetric measures
58. Epizootiology of trypanosomiasis in livestock in East and Central Africa
59. International co-operation: Past and present